Source: Oncology reports. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA
ABNT
FOLGUEIRA, Maria Aparecida Azevedo Koike et al. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy. Oncology reports, v. 22, n. 4, p. 805-813, 2009Tradução . . Disponível em: https://doi.org/10.3892/or_00000503. Acesso em: 08 out. 2024.APA
Folgueira, M. A. A. K., Brentani, H., Carraro, D. M., Barros Filho, M. de C., Katayama, M. L. H., Abreu, A. P. S. de, et al. (2009). Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy. Oncology reports, 22( 4), 805-813. doi:10.3892/or_00000503NLM
Folgueira MAAK, Brentani H, Carraro DM, Barros Filho M de C, Katayama MLH, Abreu APS de, Barbosa EM, Oliveira CT de, Patrão DFC, Mota LD, Mourão Netto M, Caldeira JRF, Brentani MM. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy [Internet]. Oncology reports. 2009 ; 22( 4): 805-813.[citado 2024 out. 08 ] Available from: https://doi.org/10.3892/or_00000503Vancouver
Folgueira MAAK, Brentani H, Carraro DM, Barros Filho M de C, Katayama MLH, Abreu APS de, Barbosa EM, Oliveira CT de, Patrão DFC, Mota LD, Mourão Netto M, Caldeira JRF, Brentani MM. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy [Internet]. Oncology reports. 2009 ; 22( 4): 805-813.[citado 2024 out. 08 ] Available from: https://doi.org/10.3892/or_00000503